Burlington Stores Total Cost of Revenue decreased by 22.3% to $1.59B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.5%, from $1.41B to $1.59B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 4.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.24B | $1.28B | $1.35B | $1.57B | $1.14B | $1.21B | $1.20B | $1.63B | $1.23B | $1.27B | $1.30B | $1.79B | $1.33B | $1.41B | $1.42B | $1.87B | $1.41B | $1.52B | $1.51B | $2.05B | $1.59B |
| QoQ Change | — | +3.0% | +5.3% | +16.3% | -27.4% | +6.5% | -1.1% | +35.7% | -24.2% | +2.8% | +2.5% | +37.8% | -25.6% | +5.8% | +0.7% | +31.7% | -24.8% | +8.2% | -0.6% | +35.9% | -22.3% |
| YoY Change | — | — | — | — | -8.5% | -5.3% | -11.1% | +3.7% | +8.3% | +4.5% | +8.3% | +10.0% | +8.0% | +11.2% | +9.3% | +4.5% | +5.6% | +7.9% | +6.5% | +9.9% | +13.5% |